Skip to main content
. 2015 Aug 31;10(8):e0137073. doi: 10.1371/journal.pone.0137073

Fig 5. Parotid ADC at different MR stages in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.

Fig 5

Compared to stage 0 (before radiotherapy), parotid ADC increased significantly at all MR stages. After initial elevation at stage 1 (≦100 days), parotid ADC gradually decreased at stage 2 (101 days to 1 year) and stage 3 (>1 year).